Home › Prostate Cancer › South Dakota
Prostate Cancer clinical trials in South Dakota
8 studies for Prostate Cancer are looking for participants at sites in South Dakota.
Cities in South Dakota
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Sanford Oncology Clinic and Pharmacy, Sioux Falls
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT04221542Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Sanford Cancer Center Oncology Clinic, Sioux Falls
- Sanford USD Medical Center - Sioux Falls, Sioux Falls
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Sanford Cancer Center Oncology Clinic, Sioux Falls
- Sanford USD Medical Center - Sioux Falls, Sioux Falls
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07200830Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Sanford Cancer Center Oncology Clinic, Sioux Falls
- Sanford USD Medical Center - Sioux Falls, Sioux Falls
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT06931340Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Sanford USD Medical Center - Sioux Falls, Sioux Falls
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 23, 2026 · NCT05946213A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Avera Cancer Institute - Aberdeen ( Site 0123), Aberdeen
- Avera Cancer Institute - Mitchell ( Site 0121), Mitchell
- Avera Cancer Institute - Pierre ( Site 0118), Pierre
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06136650Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Aberdeen
- Research Site, Mitchell
- Research Site, Pierre
- and 2 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 15, 2026 · NCT07711002Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Sanford Oncology Clinic and Pharmacy, Sioux Falls
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 15, 2026 · NCT07493512From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.